Recursion Pharmaceuticals Inc (RXRX)

05:25 AM

Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com

05:25 AM

Nov 28, 2025

Recursion Pharmaceuticals Gains Traction with Strategic Developments - timothysykes.com

Nov 28, 2025

Nov 28, 2025

Recursion Pharmaceuticals’ Advances Boost Market Confidence - timothysykes.com

Nov 28, 2025

Nov 28, 2025

Tangible book value per share of Recursion Pharmaceuticals, Inc. Class A – BIVA:RXRX - TradingView

Nov 28, 2025

Nov 27, 2025

Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock - AOL.com

Nov 27, 2025

Nov 26, 2025

RXRX SEC FilingsRecursion Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Nov 26, 2025

Nov 26, 2025

CFO Taylor Surrenders 2,271 Of Recursion Pharmaceuticals Inc [RXRX] - TradingView

Nov 26, 2025

Nov 26, 2025

[Form 4] RECURSION PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan

Nov 26, 2025

Nov 26, 2025

Recursion Pharmaceuticals registers 7.1 million shares for Tempus AI resale By Investing.com - Investing.com Nigeria

Nov 26, 2025

Nov 26, 2025

Recursion Pharmaceuticals registers 7.1 million shares for Tempus AI resale - Investing.com

Nov 26, 2025

Nov 26, 2025

Recursion Pharmaceuticals Registers Resale of 7 Million Shares - TipRanks

Nov 26, 2025

Nov 26, 2025

Recursion Pharmaceuticals Registers Resale of Tempus Shares - TradingView

Nov 26, 2025

Nov 26, 2025

[8-K] RECURSION PHARMACEUTICALS, INC. Reports Material Event | RXRX SEC FilingForm 8-K - Stock Titan

Nov 26, 2025

Nov 26, 2025

Form 424B7 RECURSION PHARMACEUTICAL - StreetInsider

Nov 26, 2025

Nov 26, 2025

RXRX files prospectus for Tempus AI resale of 7.09M shares - Stock Titan

Nov 26, 2025

Nov 26, 2025

Is the Market Bullish or Bearish on Recursion Pharmaceuticals Inc? - Benzinga

Nov 26, 2025

Nov 25, 2025

A Look at Recursion Pharmaceuticals’s Valuation Following New CEO, Narrowed Losses, and Milestone Partnership Payment - Yahoo Finance

Nov 25, 2025

Nov 24, 2025

Why Skyrocketed Recursion Pharmaceuticals, Inc. (RXRX) Today - MSN

Nov 24, 2025

Nov 24, 2025

Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? - The Globe and Mail

Nov 24, 2025

Nov 23, 2025

Recursion Pharmaceuticals (RXRX): Evaluating Valuation After Fresh Leadership, Pharma Partnerships, and Market Optimism - simplywall.st

Nov 23, 2025

Nov 23, 2025

Recursion Pharmaceuticals (RXRX) Stock Today: ‘Hold’ Rating, New Institutional Buying and AI Drug Discovery Hype — November 23, 2025 - ts2.tech

Nov 23, 2025

Nov 22, 2025

Top Biotech Stocks To Watch TodayNovember 21st - MarketBeat

Nov 22, 2025

Nov 22, 2025

Recursion (RXRX) Jumps 8% on Bargain-Hunting - Finviz

Nov 22, 2025

Nov 22, 2025

Recursion Pharmaceuticals (RXRX) Stock: CEO Sells $5.8 Million in Shares Following Exscientia Merger - CoinCentral

Nov 22, 2025

Nov 21, 2025

Recursion Pharmaceuticals Surpasses Third-Quarter Expectations, Announces Milestone with Roche - StocksToTrade

Nov 21, 2025

Nov 21, 2025

Recursion Pharmaceuticals Surges Amid CEO Transition and Strong Q3 Results - StocksToTrade

Nov 21, 2025

Nov 21, 2025

Soaring Stock: Recursion Pharmaceuticals’ Latest Surge - timothysykes.com

Nov 21, 2025

Nov 21, 2025

Recursion seeks to deliver results, and a VC sees a wave of M&A coming - statnews.com

Nov 21, 2025

Nov 21, 2025

Recursion Pharmaceuticals Stock (RXRX) Opinions on Q3 Earnings Miss - Quiver Quantitative

Nov 21, 2025

Nov 21, 2025

Is Recursion Pharmaceuticals Inc. (RXRX) One of the Best Mid Cap Stocks to Buy According to Hedge Funds? - Finviz

Nov 21, 2025

Nov 21, 2025

Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results - statnews.com

Nov 21, 2025

Nov 21, 2025

Recursion’s Khan Era: Proving AI Can Crack Drug Discovery - WebProNews

Nov 21, 2025

Nov 20, 2025

RXRX’s Anemic Revenue Misses Estimates - timothysykes.com

Nov 20, 2025

Nov 20, 2025

How Recursion Pharmaceuticals Inc. stock trades during market volatilityQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com

Nov 20, 2025

Nov 19, 2025

CFO Taylor Surrenders 11,908 Of Recursion Pharmaceuticals Inc [RXRX] - TradingView

Nov 19, 2025

Nov 19, 2025

Is Recursion Pharmaceuticals a Meme Stock? - MSN

Nov 19, 2025

Nov 19, 2025

How Recursion Pharmaceuticals Inc. stock reacts to bond yields2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com

Nov 19, 2025

Nov 19, 2025

CEO Gibson Files To Sell 40,000 Of Recursion Pharmaceuticals Inc [RXRX] - TradingView

Nov 19, 2025

Nov 19, 2025

Is Recursion Pharmaceuticals Inc. stock poised for growth2025 Analyst Calls & Fast Entry High Yield Stock Tips - newser.com

Nov 19, 2025

Nov 18, 2025

Recursion Pharmaceuticals (RXRX) Is Down 11.7% After Revenue Miss and CEO Transition – Has the Bull Case Changed? - simplywall.st

Nov 18, 2025

Nov 18, 2025

Will earnings trigger a reversal in Recursion Pharmaceuticals Inc.Analyst Downgrade & High Yield Stock Recommendations - newser.com

Nov 18, 2025

Nov 18, 2025

Recursion Pharmaceuticals, Inc.Class A Common Stock (NQ: RXRX - Markets Financial Content

Nov 18, 2025

Nov 18, 2025

Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader? (RXRX) - Seeking Alpha

Nov 18, 2025

Nov 18, 2025

Why Recursion Pharmaceuticals, Inc. (RXRX) Went Down On Monday? - MSN

Nov 18, 2025